Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. - Wikidata - awgldk - TriplyDB

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.

http://www.wikidata.org/entity/Q33751063

about

Neuroinflammation and psychiatric illness Bipolar disorder and mechanisms of action of mood stabilizers Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology Implications of glial nitric oxide in neurodegenerative diseases A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates Understanding the role of P2X7 in affective disorders-are glial cells the major players?Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder Chronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient mice Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.Resilience and Vulnerability to Pain and Inflammation in the Hippocampus.Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.Brain lipid concentrations in bipolar disorder.Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.The immunology of bipolar disorder DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.Cytokines in bipolar disorder: paving the way for neuroprogression.A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.RETRACTED: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.Swift Acetate Glial Assay (SAGA): an accelerated human ¹³C MRS brain exam for clinical diagnostic use.Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging.Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites.Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder The somatic common deletion in mitochondrial DNA is decreased in schizophrenia Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

P2860

Q21245244-EA33A547-7FD2-4ADC-A03E-74F010A8A0BA Q22252332-DCAB431F-96F7-49E5-9F3A-4DD55E99D053 Q26765419-730AC834-B9DE-4F28-A308-8F023901BC70 Q26777966-4A478AE9-DACE-4588-86C8-B9C6377B0125 Q26782867-FAC18B7D-5B0A-478D-9DD9-D7F2D66BB0EA Q26782894-C9F7D5FD-79F2-476D-8B9D-D5A7C7B6080A Q26786354-EF062652-34D6-4775-9169-2CBF7EBAC6C2 Q26798961-FC2AFFE1-D42F-4BDB-8A33-2E5C57B62557 Q26850084-6D647B70-391E-4F9A-881C-F5BF2BB01832 Q26862278-057166A2-5181-4C23-ACFF-260B2C0CB73C Q28539744-33ADD8AB-27FF-4CF2-8600-991223E3F600 Q30511829-54C4EDFE-E1BD-40A5-9811-9FBB07248E40 Q33624442-BDA6B45C-EB08-4B14-AA6B-3C4A0E4934B0 Q33637566-A1C8B9E6-136F-488C-81C0-38C0F09D00FB Q33653214-BC85826B-7395-41A5-BBB5-906E7F7D5F36 Q33664124-0BD62953-C78A-400A-A0ED-2F41E1857468 Q33698965-0F90D1E5-E968-4F3D-996E-72C9B40384B4 Q33727970-F304F891-84A2-44C5-9B19-C4B99808E850 Q33751814-31BE6CF8-DC29-44E6-8FBE-36D7C98E8F24 Q33784486-0021348C-1775-40CB-8041-B96F380F529C Q33993276-87DD5B09-D8AC-4F14-82DD-856C2C512AC3 Q34233926-3F7EED46-D349-45DB-A67E-A8B065342DFF Q34238394-1F1DE77F-E248-4327-836E-C865E59697B5 Q34279077-D8825955-5E70-412F-A0D5-2BE5397B3B4C Q34352492-1E14C1E6-FC7E-4DE5-8A9A-F493B7CA3579 Q34361280-922ECED3-FF14-484E-AB2C-9C58F903EF31 Q34374526-B4A42328-B9B4-46C7-81C5-B03282949813 Q34444465-E0A2A152-4220-4F17-AAA8-37BDB3A86CA7 Q34461400-B2CB0144-FE58-4423-8276-A92A92162912 Q34566029-BBE32147-9DC5-4BF5-990C-A0F02866C4EC Q34613536-AB7102CE-0034-4075-BE77-CB505C533121 Q35053349-B90F24EE-F4B4-4CEC-98BD-DB01509DAAC6 Q35162073-3E712570-9A2B-4CD4-8F82-9D8AFC0465E2 Q35218379-3E997C08-F053-4D7C-82CD-9AE1CF2B179C Q35284832-9BC9ED28-77EE-4270-B5C6-AD4A32075662 Q35306297-6558C404-DD06-48CB-B506-4769BDADC31E Q35476477-3D4F9805-C9AE-4CDD-B5B2-615B5D705067 Q35496330-4C3863B9-072E-4D14-95F7-FF35C7B71FD0 Q35661134-215AB27F-9CD2-428C-A338-E4D07198E8AD Q35662070-A1AEF650-3556-430B-A8C9-A226E37C1947

P2860

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.

http://www.wikidata.org/entity/Q33751063

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@ast

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@en

type

label

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@ast

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@en

prefLabel

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@ast

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@en

P1433

Q33751063-712BE7FD-5D09-4954-B3F2-93BE32A20648

P1476

Q33751063-8AD2E851-01B9-4FFD-8073-C1B5BB185C04

P2093

Q33751063-4182ED1F-5F13-4981-8DA0-69E5758DF81C

Q33751063-5A2673CD-7343-4298-977E-F7915B0C9BC1

Q33751063-8F34721B-3608-41FA-89C5-B1BE543D12F2

Q33751063-F649F1F0-F6F9-4C60-BE0F-7E0830DE2FD2

P2860

Q33751063-08D14164-8B62-4CAF-9CF8-5D05EAE195BD

Q33751063-0A853F35-DF40-4ADF-908F-3F71464EC4D1

Q33751063-1B955320-23B5-417A-AAC4-54315557601C

Q33751063-1CA29223-F3E1-41A4-8062-2F85B74BD632

Q33751063-2405971F-64EC-4FE2-B177-D57659EDC66A

Q33751063-2D9928D1-BD68-4A87-9BAB-485C068D682F

Q33751063-2E586620-4AA2-487D-A965-FDFCBBA16EF5

Q33751063-3362F5A2-63F4-4299-8780-4C34C3BE9E05

Q33751063-3E70A680-EE7F-410A-86CF-1341D395F9EB

Q33751063-3EA3CEDE-FE3D-4703-80A0-45B0E65F8ED9

P2888

Q33751063-6C25031B-21C4-4C6C-BF88-3875B0AF65E9

P304

Q33751063-CF4421D5-1EC1-4C0B-8769-6ACD8A13D09F

P31

Q33751063-EA3E15D0-B530-40F5-AAEB-2A21C214E7E2

P356

Q33751063-AE11B751-701E-4BB5-B98D-336F211A4E79

P407

Q33751063-30D8C2D4-1C1C-494B-9C26-BFF5461A9D21

P433

Q33751063-938B27AA-FED2-493C-80A2-3878BACEADED

P478

Q33751063-A6F3512D-F5F7-4F9C-BCBC-195510090B59

P577

Q33751063-F02FBAF8-B2CD-46A1-B593-140D57625463

P5875

Q33751063-A89B4BDC-1E5A-44D9-AFEE-003511BF34B4

P698

Q33751063-07528FC9-C661-4262-B727-A7B375686EFF

P921

Q33751063-013CE43F-E4FD-4E14-99AB-9DA27E53F0A7

P932

Q33751063-F59C889F-27EC-4AF0-B8BB-3035B3C89248

P356

P1433

Molecular Psychiatry

P1476

Increased excitotoxicity and n ...... rom bipolar disorder patients.

@en

P2093

G J Harry

http://www.w3.org/2001/XMLSchema#string

H W Kim

http://www.w3.org/2001/XMLSchema#string

J S Rao

http://www.w3.org/2001/XMLSchema#string

S I Rapoport

http://www.w3.org/2001/XMLSchema#string

P2860

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

IRAK: a kinase associated with the interleukin-1 receptor

Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

TRAF6 is a signal transducer for interleukin-1

Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex

MyD88: an adapter that recruits IRAK to the IL-1 receptor complex

Structure, regulation and function of NF-kappa B

Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

P2888

P304

384-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MP.2009.47

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26258800

http://www.w3.org/2001/XMLSchema#string

P698

19488045

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

2844920

http://www.w3.org/2001/XMLSchema#string